Macular Degeneration Stem Cell Clinical Trials

As of early 2019 there were 233 clinical trials for macular degeneration registered with the national institutes of health.

Macular degeneration stem cell clinical trials.

A pioneering clinical trial of a new treatment derived from embryonic stem cells for people with wet age related macular degeneration amd has been initiated at moorfields eye hospital in london following a successful operation on a 60 year old woman. Found 71 clinical trials a phase 2 randomized double masked placebo controlled clinical study to evaluate the safety efficacy and pharmacokinetics of subcutaneous injections of elamipretide in subjects with age related macular degeneration with geographic atrophy reclaim 2. She is the first of 10 persons with wet amd who will receive the stem cell treatment as part of an 18 month clinical trial to test the safety and effectiveness of this procedure. 1 biological causes researchers are looking into how the body operates on a cellular level so they can better understand what causes macular degeneration.

The clinical trial was designed to determine if people at risk for the development of the advanced stages of age related macular degeneration amd could lower their risk for progression and associated vision loss by ingesting high dose micronutrient supplements.